Skip to main content
. 2020 Apr 21;35(4):866–875. doi: 10.1093/humrep/deaa040

Table V. Outcomes of the assessed PREs.

PRE items
Mean (SD)
T1 (FET) T2 (pregnancy test) Treatment effect Time effect Interaction
Anxiety/sadness about missing ovulation*
Home-based monitoring n = 95; 1.73 (0.85) n = 89; 1.97 (0.96) P = 0.66 P = 0.047 P = 0.594
Hospital-based monitoring n = 88; 1.60 (0.82) n = 85; 1.74 (0.93)
Empowerment during treatment**
Home-based monitoring n = 95; 3.23 (0.92) n = 89; 3.29 (0.92) P = 0.001 P = 0.41 P = 0.83
Hospital-based monitoring n = 88; 2.90 (0.90) n = 85; 3.00 (0.95)
Discretion of method**
Home-based monitoring n = 94; 4.13 (0.79) n = 88; 4.18 (0.78) P = 0.000 P = 0.66 P = 0.30
Hospital-based monitoring n = 86; 3.84 (0.85) n = 85; 3.71 (0.90)
Satisfaction with method**
Home-based monitoring n = 94; 3.83 (1.05) n = 88; 3.95 (0.97) P = 0.17 P = 0.97 P = 0.187
Hospital-based monitoring n = 86; 3.83 (0.75) n = 85; 3.69 (0.82)
Partner?
Home-based monitoring Yes n = 89, No n = 5 Yes n = 86, No n = 3 NA NA NA
Hospital-based monitoring Yes n = 81, No n = 6 Yes n = 79, No n = 6
Partner involvement during treatment**
Home-based monitoring n = 89; 3.99 (0.96) n = 85; 4.01 (0.85) P = 0.069 P = 0.71 P = 0.485
Hospital-based monitoring n = 80; 4.24 (0.83) n = 78; 4.21 (0.93)

Data for the two randomisation groups of the Antarctica-2 RCT after completion of ovulation monitoring but before FET (T = 1) and before pregnancy test (T = 2).

*Scores scale: 1 = indicating no problem; 2 = indicating slight problems; 3 = indicating moderate problems; 4 = indicating severe problems; 5 = indicating extreme problems. **Scores scale: 1 = no empowerment/discretion/satisfaction/partner involvement at all; 2 = no empowerment/discretion/satisfaction/partner involvement; 3 = neutral; 4 = experienced empowerment/discretion/satisfaction/partner involvement; 5 = experienced very much empowerment/discretion/satisfaction/partner involvement.